MANAGEMENT

Raghav Chari joined Azurity in 2025 as Chief Business and Innovation Officer, bringing over 25 years of experience in the biopharmaceutical arena, where he successfully built and led small and large organizations across the R&D and commercialization continuum.

Raghav came to Azurity from Covis Pharma, where he was Chief Innovation Officer. Prior to Covis, he was President of Promius Pharma, a dermatology and neurology company, and Executive Vice President of Proprietary Products at Dr. Reddy’s Laboratories. Early in his career, Raghav worked at McKinsey and Company, followed by stints at two small drug discovery/early development-stage biotech companies where he played hybrid R&D and commercial roles. Raghav has founded and continues to be involved in several startups that work at the interface between drug discovery and technology. He has also been responsible for over 50 licensing and product development deals in the biopharmaceutical space.

Raghav holds a Ph.D. in Physics from Princeton University, and a B.S. in Mathematics from the California Institute of Technology.